Volume 6, Issue 1 (6-2022)                   CRMS 2022, 6(1): 25-33 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Fattahii F S. Biocompatible Gelatin Nanofibers as Potential Anticancer Drug Delivery Systems. CRMS 2022; 6 (1) : 4
URL: http://crms.mubabol.ac.ir/article-1-128-en.html
isffahan university of technology , fattahi_farnaz@yahoo.com
Abstract:   (2528 Views)

Abstract: Today, cancer remains a worldwide and severe public health challenge. Cancer is one of the reasons of disease and mortality global; chiefly owing to problems in treatment-associated, recurrence rates, metastasis and late diagnosis. In latest years, with the development of nano-materials, the investigation of drug delivery systems has become a novel field of cancer therapy. Local drug delivery systems are hopeful apparatuses in modern medicine because they can promise the release of drugs with the kinetics necessary; via specific applications and a reduction in unwanted side effects. Drug delivery systems are typically composed of delivery carriers, antitumor drugs, and even target molecules. Over the years, a wide variation of polymeric nano-mats has been explored as implantable single drug delivery systems. Gelatin is a natural polymer with highly biocompatibility and non-toxicity that is manufactured via thermal denaturalization of collagen, which is available in animal skin and bones in the presence of dilute acids. On the other hand, electrospinning is a widely considered method for the progress of drug-delivery nano-mats. 3-D Gelatin electrospun nanofibers (with great porosity and small pore size) can be applied to deliver anti-cancer drugs (like Doxorubicin, Tamoxifen and Curcumin) in cancer therapy. This mini review presents the gelatin nanofibrous anti-cancer drug delivery carriers for clinical application of cancer nanomedicine in the future.
 

Article number: 4
Full-Text [PDF 889 kb]   (1874 Downloads)    
Type of Study: Review Article | Subject: بیوشیمی
Received: 2022/11/28 | Accepted: 2022/12/30 | Published: 2023/01/29

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2026 CC BY-NC 4.0 | Current Research in Medical Sciences

Designed & Developed by : Yektaweb